PMC:7534795 / 83815-84055 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T398","span":{"begin":124,"end":134},"obj":"Body_part"},{"id":"T399","span":{"begin":152,"end":158},"obj":"Body_part"}],"attributes":[{"id":"A398","pred":"fma_id","subj":"T398","obj":"http://purl.org/sig/ont/fma/fma7199"},{"id":"A399","pred":"fma_id","subj":"T399","obj":"http://purl.org/sig/ont/fma/fma7203"}],"text":"n, 2016). Additionally, evidence demonstrates intraperitoneal infusions of 17,18-EEQ and 19,20-EDP protect against allergic intestinal inflammation and kidney fibrosis in corresponding mouse models (Kunisawa et al., 2015; Sharma et al., 201"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T107","span":{"begin":152,"end":158},"obj":"Body_part"}],"attributes":[{"id":"A107","pred":"uberon_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"}],"text":"n, 2016). Additionally, evidence demonstrates intraperitoneal infusions of 17,18-EEQ and 19,20-EDP protect against allergic intestinal inflammation and kidney fibrosis in corresponding mouse models (Kunisawa et al., 2015; Sharma et al., 201"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T486","span":{"begin":115,"end":123},"obj":"Disease"},{"id":"T487","span":{"begin":124,"end":147},"obj":"Disease"},{"id":"T488","span":{"begin":135,"end":147},"obj":"Disease"}],"attributes":[{"id":"A486","pred":"mondo_id","subj":"T486","obj":"http://purl.obolibrary.org/obo/MONDO_0004980"},{"id":"A487","pred":"mondo_id","subj":"T487","obj":"http://purl.obolibrary.org/obo/MONDO_0002269"},{"id":"A488","pred":"mondo_id","subj":"T488","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"n, 2016). Additionally, evidence demonstrates intraperitoneal infusions of 17,18-EEQ and 19,20-EDP protect against allergic intestinal inflammation and kidney fibrosis in corresponding mouse models (Kunisawa et al., 2015; Sharma et al., 201"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T541","span":{"begin":124,"end":134},"obj":"http://purl.obolibrary.org/obo/UBERON_0000160"},{"id":"T542","span":{"begin":124,"end":134},"obj":"http://www.ebi.ac.uk/efo/EFO_0000834"},{"id":"T543","span":{"begin":152,"end":158},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T544","span":{"begin":152,"end":158},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T545","span":{"begin":152,"end":158},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T546","span":{"begin":185,"end":190},"obj":"http://purl.obolibrary.org/obo/CLO_0007836"}],"text":"n, 2016). Additionally, evidence demonstrates intraperitoneal infusions of 17,18-EEQ and 19,20-EDP protect against allergic intestinal inflammation and kidney fibrosis in corresponding mouse models (Kunisawa et al., 2015; Sharma et al., 201"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T619","span":{"begin":75,"end":84},"obj":"Chemical"},{"id":"T620","span":{"begin":81,"end":84},"obj":"Chemical"},{"id":"T622","span":{"begin":89,"end":98},"obj":"Chemical"}],"attributes":[{"id":"A619","pred":"chebi_id","subj":"T619","obj":"http://purl.obolibrary.org/obo/CHEBI_72853"},{"id":"A620","pred":"chebi_id","subj":"T620","obj":"http://purl.obolibrary.org/obo/CHEBI_144559"},{"id":"A621","pred":"chebi_id","subj":"T620","obj":"http://purl.obolibrary.org/obo/CHEBI_72852"},{"id":"A622","pred":"chebi_id","subj":"T622","obj":"http://purl.obolibrary.org/obo/CHEBI_72653"}],"text":"n, 2016). Additionally, evidence demonstrates intraperitoneal infusions of 17,18-EEQ and 19,20-EDP protect against allergic intestinal inflammation and kidney fibrosis in corresponding mouse models (Kunisawa et al., 2015; Sharma et al., 201"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T191","span":{"begin":135,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"n, 2016). Additionally, evidence demonstrates intraperitoneal infusions of 17,18-EEQ and 19,20-EDP protect against allergic intestinal inflammation and kidney fibrosis in corresponding mouse models (Kunisawa et al., 2015; Sharma et al., 201"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T215","span":{"begin":152,"end":167},"obj":"Phenotype"}],"attributes":[{"id":"A215","pred":"hp_id","subj":"T215","obj":"http://purl.obolibrary.org/obo/HP_0030760"}],"text":"n, 2016). Additionally, evidence demonstrates intraperitoneal infusions of 17,18-EEQ and 19,20-EDP protect against allergic intestinal inflammation and kidney fibrosis in corresponding mouse models (Kunisawa et al., 2015; Sharma et al., 201"}

{"project":"2_test","denotations":[{"id":"33031856-26065911-84039029","span":{"begin":216,"end":220},"obj":"26065911"}],"text":"n, 2016). Additionally, evidence demonstrates intraperitoneal infusions of 17,18-EEQ and 19,20-EDP protect against allergic intestinal inflammation and kidney fibrosis in corresponding mouse models (Kunisawa et al., 2015; Sharma et al., 201"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2398","span":{"begin":185,"end":190},"obj":"Species"},{"id":"2413","span":{"begin":75,"end":84},"obj":"Chemical"},{"id":"2414","span":{"begin":89,"end":98},"obj":"Chemical"},{"id":"2431","span":{"begin":115,"end":147},"obj":"Disease"},{"id":"2432","span":{"begin":152,"end":167},"obj":"Disease"}],"attributes":[{"id":"A2398","pred":"tao:has_database_id","subj":"2398","obj":"Tax:10090"},{"id":"A2431","pred":"tao:has_database_id","subj":"2431","obj":"MESH:D007249"},{"id":"A2432","pred":"tao:has_database_id","subj":"2432","obj":"MESH:D005355"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"n, 2016). Additionally, evidence demonstrates intraperitoneal infusions of 17,18-EEQ and 19,20-EDP protect against allergic intestinal inflammation and kidney fibrosis in corresponding mouse models (Kunisawa et al., 2015; Sharma et al., 201"}